NEDD9 (neural precursor cell expressed, developmentally down-regulated 9) has been associated with the risk of developing Parkinson's disease and late-onset Alzheimer's disease, a disorder whose pathogenesis is modulated by cholesterol levels and cholesterol-related genes [69], [70], [78]. The gene discussed is NEDD9; the disease is late-onset Alzheimers disease.